早期针刀在腰椎间盘突出症患者行神经阻滞联合臭氧消融术后的干预效果研究OA
Clinical observation of early needle-knife intervention following nerve block combined with ozone ablation for lumbar disc herniation
目的:观察在神经阻滞联合臭氧消融术后早期(3~7d)实施针刀干预,对腰椎间盘突出症患者疼痛和功能恢复的影响.方法:选取2022年1月—2024年12月我院收治的腰椎间盘突出症患者196例,随机分为观察组与对照组各98例.两组患者均接受神经阻滞联合臭氧消融术治疗,对照组术后仅接受常规康复治疗,观察组于术后3~7d接受针刀干预1次.比较两组在治疗前、治疗后3d、2周、1个月及6个月的以下指标:日本骨科协会(JOA)下腰痛评分、疼痛视觉模拟评分(VAS)、Oswestry功能障碍指数(ODI),采用改良Macnab标准评估治疗有效率,并检测两组患者的红细胞沉降率(ESR)、白细胞计数(WBC)、全身炎症反应指数(SIRI)和全身免疫炎症指数(SII).结果:观察组术后各时间点的JOA、VAS及ODI均显著优于对照组(P<0.05),且观察组在术后1个月及6个月的有效率显著高于对照组(P<0.05);两组术后3 d的ESR、WBC、SIRI、SII水平差异无统计学意义(P>0.05).结论:神经阻滞联合臭氧消融术治疗腰椎间盘突出症的疗效明确,术后早期联合针刀干预具有协同增效作用,可进一步缓解疼痛、改善功能并提升远期疗效.
Objective To evaluate the effect of early needle knife intervention following nerve block and ozone ablation in patients with lumbar disc herniation(LDH).Methods 196 LDH patients were equally allocated to either the observation group or control group.Both groups underwent nerve block combined with ozone ablation.The observation group received additional needle knife therapy 3-7 days postoperatively,whereas the control group received conventional rehabilitation only.Outcomes including JOA,VAS,ODI,modified Macnab criteria,ESR,WBC,SIRI,and SII were assessed at baseline and 3 days,2 weeks,1 month,and 6 months post-treatment.Results The observation group demonstrated significantly better JOA,VAS,and ODI scores at all postoperative time points(P<0.05),along with higher effectiveness rates at 1 and 6 months(P<0.05).No significant intergroup differences were observed in ESR,WBC,SIRI,or SII levels at 3 days post-treatment(P>0.05).Conclusion Early needle knife intervention enhances the efficacy of nerve block and ozone ablation,providing additional benefits in pain relief,functional recovery,and long-term outcomes in LDH patients.
徐珊珊;王琼;魏崇
川北医学院(南充 637000)||遂宁市第三人民医院疼痛康复科(遂宁 629000)遂宁市中心医院疼痛科(遂宁 629000)川北医学院(南充 637000)||川北医学院附属遂宁中医医院(遂宁 629000)
医药卫生
针刀疗法腰椎间盘突出症神经阻滞臭氧消融术
Needle-knife therapylumbar disc herniationnerve blockozone ablation
《中国中西医结合外科杂志》 2026 (1)
19-23,5
四川省中医药管理局科学技术研究专项课题(2024MS398)
评论